Movement Alert｜WuXi AppTec Rises 3.36% in Regular Trading, Sustained Large-Scale Buybacks Combined with Innovative Drug Sector Recovery

Market Focus06-24 09:34

On June 24, WuXi AppTec rose 3.36% in regular trading, trading at 135.2 HKD/share, with turnover of 44.19 million HKD.

On the news front, the company recently completed its H-Share Award Trust Plan with approximately 2.5 billion HKD in share repurchases, accumulating roughly 20.15 million H-shares representing about 0.68% of total share capital. Simultaneously, since June 12, the company has been executing a nearly 1 billion RMB A-share buyback program at a pace of approximately 100 million RMB per day, with repurchased shares designated for employee stock ownership plans. Additionally, the company has filed a lawsuit against the U.S. Department of Defense over its erroneous inclusion on a military-related entity list, actively defending its rights.

The broader innovative drug sector continues to warm up, with sector peers GenScript Biotech rising 3.86%, WuXi XDC up 2.95%, and WuXi Biologics gaining 1.61%, reflecting gradual restoration of industry confidence.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154630996?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154630996","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi AppTec Rises 3.36% in Regular Trading, Sustained Large-Scale Buybacks Combined with Innovative Drug Sector Recovery","media":"Market Focus","content":"<p><p>On June 24, WuXi AppTec rose 3.36% in regular trading, trading at 135.2 HKD/share, with turnover of 44.19 million HKD.</p><p>On the news front, the company recently completed its H-Share Award Trust Plan with approximately 2.5 billion HKD in share repurchases, accumulating roughly 20.15 million H-shares representing about 0.68% of total share capital. Simultaneously, since June 12, the company has been executing a nearly 1 billion RMB A-share buyback program at a pace of approximately 100 million RMB per day, with repurchased shares designated for employee stock ownership plans. Additionally, the company has filed a lawsuit against the U.S. Department of Defense over its erroneous inclusion on a military-related entity list, actively defending its rights.</p><p>The broader innovative drug sector continues to warm up, with sector peers GenScript Biotech rising 3.86%, WuXi XDC up 2.95%, and WuXi Biologics gaining 1.61%, reflecting gradual restoration of industry confidence.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi AppTec Rises 3.36% in Regular Trading, Sustained Large-Scale Buybacks Combined with Innovative Drug Sector Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi AppTec Rises 3.36% in Regular Trading, Sustained Large-Scale Buybacks Combined with Innovative Drug Sector Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, WuXi AppTec rose 3.36% in regular trading, trading at 135.2 HKD/share, with turnover of 44.19 million HKD.</p><p>On the news front, the company recently completed its H-Share Award Trust Plan with approximately 2.5 billion HKD in share repurchases, accumulating roughly 20.15 million H-shares representing about 0.68% of total share capital. Simultaneously, since June 12, the company has been executing a nearly 1 billion RMB A-share buyback program at a pace of approximately 100 million RMB per day, with repurchased shares designated for employee stock ownership plans. Additionally, the company has filed a lawsuit against the U.S. Department of Defense over its erroneous inclusion on a military-related entity list, actively defending its rights.</p><p>The broader innovative drug sector continues to warm up, with sector peers GenScript Biotech rising 3.86%, WuXi XDC up 2.95%, and WuXi Biologics gaining 1.61%, reflecting gradual restoration of industry confidence.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"","article_id":"1154630996","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154630996","pubTimestamp":1782264879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, WuXi AppTec rose 3.36% in regular trading, trading at 135.2 HKD/share, with turnover of 44.19 million HKD.On the news front, the company recently completed its H-Share Award Trust Plan...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"运动快讯|药明康德常规交易涨3.36%持续大手笔回购叠加创新药板块回暖","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1},"content_text":"On June 24, WuXi AppTec rose 3.36% in regular trading, trading at 135.2 HKD/share, with turnover of 44.19 million HKD.On the news front, the company recently completed its H-Share Award Trust Plan with approximately 2.5 billion HKD in share repurchases, accumulating roughly 20.15 million H-shares representing about 0.68% of total share capital. Simultaneously, since June 12, the company has been executing a nearly 1 billion RMB A-share buyback program at a pace of approximately 100 million RMB per day, with repurchased shares designated for employee stock ownership plans. Additionally, the company has filed a lawsuit against the U.S. Department of Defense over its erroneous inclusion on a military-related entity list, actively defending its rights.The broader innovative drug sector continues to warm up, with sector peers GenScript Biotech rising 3.86%, WuXi XDC up 2.95%, and WuXi Biologics gaining 1.61%, reflecting gradual restoration of industry confidence.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154630996","isCrawlerRequest":true}